Karim Chamie

About

Dr. Karim Chamie is an Associate Professor in the Department of Urology at UCLA, affiliated with the Ronald Reagan UCLA Medical Center and UCLA Medical Center, Santa Monica. He specializes in urologic oncology, with a particular emphasis on bladder cancer, offering comprehensive cancer care for patients with bladder, kidney, prostate, and testicular cancers. His research interests include studying factors driving the widespread underutilization of effective measures for patients with urological malignancies. Dr. Chamie completed his fellowship in the Society of Urologic Oncology at UCLA from 2009 to 2012 and his health services research fellowship at UCLA from 2009 to 2011. He earned his MD from USC School of Medicine in 2003 and his MSHS in Health Services Research from UCLA School of Public Health in 2010. His residency in urology was completed at UC Davis Medical Center between 2005 and 2009, following a surgery internship there from 2003 to 2004. He is board-certified in urology by the American Board of Urology since 2015. Dr. Chamie has contributed to research on the impact of bladder cancer diagnosis on smoking behavior, quality of care in bladder cancer patients, compliance with treatment guidelines, secondary malignancies among germ cell tumor survivors, and the risks associated with Agent Orange exposure among Vietnam War veterans. His work has been recognized in the context of recent advances, including the FDA approval of immunotherapy drug combinations for…

Research topics

• Internal medicine
• Medicine
• Oncology
• Urology
• Anesthesia
• Intensive care medicine
• Nursing
• Pharmacology
• Surgery

Selected publications

• Bladder Cancer

  JAMA · 2020 · 1747 citations

  IMPORTANCE: Bladder cancer is a common malignancy in women and is the fourth most common malignancy in men. Bladder cancer ranges from unaggressive and usually noninvasive tumors that recur and commit patients to long-term invasive surveillance, to aggressive and invasive tumors with high disease-specific mortality. OBSERVATIONS: Advanced age, male sex, and cigarette smoking contribute to the development of bladder cancer. Bladder tumors can present with gross or microscopic hematuria, which is…

  DOI

• Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial

  The Lancet Oncology · 2020 · 134 citations

  DOI

• Peripherally Acting μ-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review

  Journal of Gastrointestinal Surgery · 2020 · 34 citations

  1st authorCorresponding

  ) in patients with POI or postoperative OIC. We will characterize potential factors that may have impacted the efficacy observed in phase 3 trials and discuss future directions for the management and treatment of POI.

  DOI

• Trends in palliative care interventions among patients with advanced bladder, prostate, or kidney cancer: A retrospective cohort study

  Urologic Oncology Seminars and Original Investigations · 2020 · 23 citations

  Senior authorCorresponding
  PublisherDOI

• The Role of Opioids and Their Receptors in Urological Malignancy: A Review

  The Journal of Urology · 2020 · 21 citations

  Senior authorCorresponding

  PURPOSE: We reviewed the literature surrounding the role of opioids and their receptors in urological malignancy. Recent studies have suggested clinically significant effects of agonism or antagonism of opioid receptors on cancer related outcomes and tumorigenesis. The focus of these efforts has centered on nonurological malignancies. However, a compelling body of evidence is growing in the fields of prostate, bladder and kidney cancer. MATERIALS AND METHODS: A systematic review of English langu…

  DOI

Recent grants

• NIH Grant F32CA144461

  NIH · $125k · 2012

Frequent coauthors

• Mark S. Litwin

  90 shared

• Andrew T. Lenis

  69 shared

• Allan J. Pantuck

  UCLA Medical Center

  63 shared

• Christopher S. Saigal

  54 shared

• Alexandra Drakaki

  50 shared

• Stephen B. Williams

  The University of Texas Medical Branch at Galveston

  48 shared

• Vishnukamal Golla

  46 shared

• Lorna Kwan

  UCLA Health

  43 shared

Education

• M.D.

  USC

• Other, Urological training

  UC Davis

Awards & honors

• Top Doctors, Los Angeles Magazine, 2021
• Dean's Scholar, University of Southern California Keck Schoo…
• Baxter Academic Scholarship
• Gerber Academic Scholarship
• Northern California Urological Association Resident Research…

Similar researchers at University of California, Los Angeles

• William Aronsonh-87
• Scott E. Eggenerh-70
• Chad Baxterh-38